According to MD Magazine, the U.S. Food and Drug Administration recently recalled four drugs from the consumer level due to various problems. One recall concerned prophylactic treatments, another concerned eye-drop, third involved hypertension drugs, and the last concerned Magnetic Resonance Thermometry overheating risks. The FDA advised patients using these therapies to contact their physicians with […]
According to MD Magazine, the U.S. Food and Drug Administration recently recalled four drugs from the consumer level due to various problems. One recall concerned prophylactic treatments, another concerned eye-drop, third involved hypertension drugs, and the last concerned Magnetic Resonance Thermometry overheating risks. The FDA advised patients using these therapies to contact their physicians with questions or concerns regarding the products.
Janssen Pharmaceutical recalled 1 lot of Ortho-Novum 1/35 tablets and 2 lots of Ortho-Novum 7/7/7 tablets because the instructions contained in the “Veridate” dispenser were not accurate. Janssen warned that following the inaccurate instructions could cause a woman to experience bleeding or become pregnant. Janssen maintains that taking the contraceptive pills as intended is a safe and effective method of contraception.
The FDA also recalled Puritan Eye Relief Drops produced by Kadesh, Inc. because an investigation revealed that the product was made under non-sterile conditions. Using the non-sterile drops could cause vision loss, scarring, or glaucoma resulting from eye infections from using the contaminated product. Use of the non-sterilized eye drops can lead to tissue damage in the cornea, anterior chamber, among other areas.
Sandoz, Inc. voluntarily recalled 1 lot of Losartan Potassium-Hydrochlorothiazide 100mg/25/mg tablets due to possible contamination with the suspected carcinogen N-Nitrosodiethylamine. The International Agency for Research on Cancer opined that the possible carcinogen naturally occurs in some foods, air pollution, water and in industrial processes. Sandoz, Inc. stated that no known illness has occurred from this possible contamination. The company did not say how the substance invaded the manufacturing process.
The FDA gave an update about the possibility of tissue overheating when patients use a magnetic resonance-guided laser interstitial thermal therapy device. The FDA updates for these devices contain detailed information about the correct temperature settings. Medtronic and Monteris Medical manufacture devices subject to this recall.
